Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.
about
Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerationsActivation of the mTOR signaling pathway is required for asthma onset.Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.Fixed-Dose Combination Inhalers.
P2860
Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tiotropium Respimat®: A Review ...... Acting β2-Adrenergic Agonists.
@en
type
label
Tiotropium Respimat®: A Review ...... Acting β2-Adrenergic Agonists.
@en
prefLabel
Tiotropium Respimat®: A Review ...... Acting β2-Adrenergic Agonists.
@en
P2860
P1433
P1476
Tiotropium Respimat®: A Review ...... Acting β2-Adrenergic Agonists.
@en
P2093
Kate McKeage
P2860
P2888
P304
P356
10.1007/S40265-015-0393-Y
P577
2015-05-01T00:00:00Z
P6179
1010567955